Neurosurgical Software Recalls Show Rising Safety Concerns in US

Researchers dug into FDA records from 2017 through 2025. They wanted to see how often software used in brain surgery got pulled from the market. The goal was to understand what's happening with these digital tools and whether they keep patients safe.

The study uncovered 20 separate recalls involving software for neurological procedures. Seven different manufacturers were behind these devices. The recall list covered four main device families: navigation for surgery, monitoring of brain activity, planning tools, and stereotactic equipment. Surgical navigation software appeared most often, making up 55 percent of all recalls.

Most of the recalled devices carried the highest safety rating, class I. These were the most serious warnings. The number of class I recalls went up steadily from 2017 to 2024. On average, class I recalls happened faster than class II ones - about four years versus ten years.

Another 16,333 reports of adverse events were tied to these software tools. The information came from FDA recall listings, MAUDE, AccessGUDID, and openFDA. The research highlights how critical software safety is for brain surgery. Better oversight will help protect patients as these digital systems spread.